These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8740643)
1. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA). Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643 [No Abstract] [Full Text] [Related]
2. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols. Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols]. Noguchi S; Miyauchi K; Nishizawa Y; Koyama H Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322 [No Abstract] [Full Text] [Related]
4. Determination of free PSA in breast cancer cytosols by IRMA. Abbate I; Musci MD; Paradiso A; Schittulli F; Correale M Int J Biol Markers; 1996; 11(1):53-4. PubMed ID: 8740644 [No Abstract] [Full Text] [Related]
5. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation. Andersen J; Bentzen SM; Poulsen HS Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941 [TBL] [Abstract][Full Text] [Related]
6. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group. Romain S; Lainé Bidron C; Martin PM; Magdelenat H Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610 [TBL] [Abstract][Full Text] [Related]
7. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms. Cren H; Lechevrel C; Roussel G; Goussard J J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):519-27. PubMed ID: 1911441 [TBL] [Abstract][Full Text] [Related]
8. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours. Romain S; Dussert C; Martin PM Eur J Cancer; 1991; 27(6):715-20. PubMed ID: 1829910 [TBL] [Abstract][Full Text] [Related]
9. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530 [TBL] [Abstract][Full Text] [Related]
10. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method. Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J Oncology; 1994; 51(5):435-9. PubMed ID: 8052485 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151 [TBL] [Abstract][Full Text] [Related]
12. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts. Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804 [TBL] [Abstract][Full Text] [Related]
13. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay. Dittadi R; Meo S; Amoroso B; Gion M Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273 [TBL] [Abstract][Full Text] [Related]
14. [Determination of estradiol receptors by immunoenzyme technique and by radioligand binding in 2134 breast tumors]. Romain S; Dussert C; Martin PM Bull Cancer; 1991; 78(4):331-40. PubMed ID: 1713518 [TBL] [Abstract][Full Text] [Related]
15. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay]. Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945 [TBL] [Abstract][Full Text] [Related]
17. Effects of the presence of progesterone receptors on the relationship between enzyme immunoassay and steroid-binding assay for oestrogen receptors. Marsigliante S; Puddefoot J; Vinson GP; Gilmore OJ Biochem Soc Trans; 1990 Aug; 18(4):565-6. PubMed ID: 2276439 [No Abstract] [Full Text] [Related]
18. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols. Goussard J; Lechevrel C; Martin PM; Roussel G Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945 [TBL] [Abstract][Full Text] [Related]
19. Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancers. Riccobon A; Zoli W; Capucci A; Volpi A; Vasini M; Bonaguri C; Flamini E; Ravaioli A; Amadori D Tumori; 1988 Apr; 74(2):167-70. PubMed ID: 3285555 [TBL] [Abstract][Full Text] [Related]
20. [Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method]. Goussard J; Lechevrel C; Martin PM; Roussel G Bull Cancer; 1985; 72(3):168-82. PubMed ID: 2416370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]